Reactive oxygen species (ROS)-responsive prodrugs, probes, and theranostic prodrugs: applications in the ROS-related diseases
P Wang, Q Gong, J Hu, X Li… - Journal of Medicinal …, 2020 - ACS Publications
Elevated levels of reactive oxygen species (ROS) have commonly been implicated in a
variety of diseases, including cancer, inflammation, and neurodegenerative diseases. In …
variety of diseases, including cancer, inflammation, and neurodegenerative diseases. In …
Progress in natural compounds/siRNA co-delivery employing nanovehicles for cancer therapy
M Ashrafizadeh, A Zarrabi, K Hushmandi… - ACS combinatorial …, 2020 - ACS Publications
Chemotherapy using natural compounds, such as resveratrol, curcumin, paclitaxel,
docetaxel, etoposide, doxorubicin, and camptothecin, is of importance in cancer therapy …
docetaxel, etoposide, doxorubicin, and camptothecin, is of importance in cancer therapy …
Combination of DNA damage, autophagy, and ERK inhibition: novel evodiamine-inspired multi-action Pt (IV) prodrugs with high-efficiency and low-toxicity antitumor …
XM Liu, Z Li, XR Xie, JQ Wang, X Qiao… - Journal of Medicinal …, 2023 - ACS Publications
Exploring multi-targeting chemotherapeutants with advantages over single-targeting agents
and drug combinations is of great significance in drug discovery. Herein, we employed …
and drug combinations is of great significance in drug discovery. Herein, we employed …
[HTML][HTML] Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis
ZB Jiang, JM Huang, YJ Xie, YZ Zhang… - Journal of Experimental …, 2020 - Springer
Background Accumulating evidence showed that regulating tumor microenvironment plays a
vital role in improving antitumor efficiency. Programmed Death Ligand 1 (PD-L1) is …
vital role in improving antitumor efficiency. Programmed Death Ligand 1 (PD-L1) is …
Evodiamine: A review of its pharmacology, toxicity, pharmacokinetics and preparation researches
Q Sun, L Xie, J Song, X Li - Journal of Ethnopharmacology, 2020 - Elsevier
Ethnopharmacological relevance Evodia rutaecarpa, a well-known herb medicine in China,
is extensively applied in traditional Chinese medicine (TCM). The plant has the effects of …
is extensively applied in traditional Chinese medicine (TCM). The plant has the effects of …
Natural product evodiamine-inspired medicinal chemistry: Anticancer activity, structural optimization and structure-activity relationship
Z Wang, Y Xiong, Y Peng, X Zhang, S Li, Y Peng… - European Journal of …, 2023 - Elsevier
It is a well-known phenomenon that natural products can serve as powerful drug leads to
generate new molecular entities with novel therapeutic utility. Evodiamine (Evo), a major …
generate new molecular entities with novel therapeutic utility. Evodiamine (Evo), a major …
[HTML][HTML] Major indole alkaloids in Evodia Rutaecarpa: the latest insights and review of their impact on gastrointestinal diseases
L Chen, Y Hu, Z Ye, L Li, H Qian, M Wu, K Qin… - Biomedicine & …, 2023 - Elsevier
Evodia rutaecarpa, the near-ripe fruit of Euodia rutaecarpa (Juss.) Benth, Euodia rutaecarpa
(Juss.) Benth. var. officinalis (Dode) Huang, or Euodia rutaecarpa (Juss.) Benth. var …
(Juss.) Benth. var. officinalis (Dode) Huang, or Euodia rutaecarpa (Juss.) Benth. var …
Evodiamine-inspired topoisomerase-histone deacetylase dual inhibitors: novel orally active antitumor agents for leukemia therapy
S Wu, Y Huang, T Wang, K Li, J Lu… - Journal of Medicinal …, 2022 - ACS Publications
On the basis of the synergism of topoisomerase (Top) and histone deacetylase (HDAC)
inhibitors in antitumor therapy, a series of novel Top/HDAC dual inhibitors were designed …
inhibitors in antitumor therapy, a series of novel Top/HDAC dual inhibitors were designed …
[HTML][HTML] Synthetic and naturally occurring heterocyclic anticancer compounds with multiple biological targets
Cancer is a complex group of diseases initiated by abnormal cell division with the potential
of spreading to other parts of the body. The advancement in the discoveries of omics and bio …
of spreading to other parts of the body. The advancement in the discoveries of omics and bio …
Progress in the medicinal chemistry of organoboron compounds
AN Tevyashova, MV Chudinov - Russian Chemical Reviews, 2021 - iopscience.iop.org
The review aims to draw attention to the latest advances in the organoboron chemistry and
therapeutic use of organoboron compounds. The synthetic strategies towards boron …
therapeutic use of organoboron compounds. The synthetic strategies towards boron …